Beyond Medical Technologies Inc. (C:DOCT*CA)
Business Focus: Sewage Treatment Facilities
Feb 29, 2024 04:58 pm ET
Beyond Medical Technologies Inc. Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - February 29, 2024) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that its auditor, BF Borgers, CPA PC ("BF Borgers"), has resigned as auditor of the Company effective February 14, 2024 and the Company has filled the vacancy by appointing Charlton & Company, CPA ("Charlton").
Jan 24, 2024 06:36 pm ET
Beyond Medical Announces Officer Change
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2024) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that Zara Kanji-Aquino has resigned as the Chief Financial Officer of the Company. The Company would like to thank Ms. Kanji-Aquino for her contributions to the Company and wishes her well on her future endeavors.
Dec 23, 2022 02:42 pm ET
CSE Bulletin: Consolidation - Beyond Medical Technologies Inc. (DOCT)
Toronto, Ontario--(Newsfile Corp. - Le 23 décembre/December 2022) - Beyond Medical Technologies Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
Dec 23, 2022 12:00 pm ET
Beyond Medical Announces Share Consolidation
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2022) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company"), announces that effective December 30, 2022, the Company will consolidate its common shares (the "Common Shares") on a ten (10) to one (1) basis (the "Consolidation").
Sep 14, 2022 07:48 pm ET
Beyond Medical Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2022) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that it has appointed BF Borgers, CPA PC ("BF Borgers"), as auditor of the Company effective August 25, 2022.
Mar 11, 2022 09:15 am ET
Beyond Medical Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2022) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to provide a corporate update on its medical face mask manufacturing subsidiary Micron Technologies Inc. ("Micron Technologies").
Jan 10, 2022 09:15 am ET
Micron Technologies Sympathizes with the Worldwide Wave of the Omicron Covid Variant and Offers Medical Grade Face Masks
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company"), through its medical face mask manufacturing subsidiary, Micron Technologies Inc. (“Micron Technologies”), sympathizes with the worldwide wave of the Omicron Covid variant and urges its clients to utilize medical grade face masks in any social settings.
Dec 06, 2021 09:15 am ET
Beyond Medical Technologies Announces Marketing Initiatives
Vancouver, British Columbia--(Newsfile Corp. - December 6, 2021) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) ("Beyond Medical" or the "Company") is pleased to announce that it has entered into an online marketing agreement ("AGORA Agreement") with AGORA Internet Relations Corp. ("AGORA") and an investor marketing agreement (the "INN Agreement") with Dig Media Inc.® d/b/a as Investing News Network® ("INN").
Nov 29, 2021 09:15 am ET
Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) ("Beyond Medical" or the "Company") is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").
Apr 27, 2021 09:15 am ET
Beyond Medical Subsidiary Micron Technologies Achieves "Amazon's Choice" Designation and Begins to Accept Bitcoin Payments for its Made in Canada Face Masks
VANCOUVER, BC, April 27, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM4) is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").
Apr 07, 2021 09:30 am ET
Beyond Medical Manufactures N95 Medical Face Masks as Third Wave of COVID-19 Surges
VANCOUVER, BC, April 7, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM4) is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").
Mar 30, 2021 09:15 am ET
Beyond Medical subsidiary Micron Technologies begins Sales of Made in Canada Face Masks to Walmart
Vancouver, BC, March 30, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM4) is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").
Feb 23, 2021 08:30 am ET
Beyond Medical Provides Update on Made in Canada Medical Face Masks and Start of Manufacturing of N95 Face Masks
VANCOUVER, BC, Feb. 23, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (FSE: 7FM4) thru its subsidiary Micron Technologies Inc is pleased to provide the following corporate update.
Feb 11, 2021 08:30 am ET
Beyond Medical Announces Appointment of Michael Kelly to its Board of Director and is Working to Close the Final Tranche of Non Brokered Private Placement
VANCOUVER, BC, Feb. 11, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM3) is pleased to announce the appointment of Michael Kelly to the Company's board of directors, effective February 11, 2021. Mr. Kelly replaces Bharat Bhushan, who has resigned as the Chief Technology Officer and as a director of the Company in order to pursue other opportunities. The Company would like to thank Mr. Bhushan for his contributions and wish him well in his future endeavours.
Feb 09, 2021 08:00 am ET
Kayan Health Partners with Predictiv Care, Inc. to Offer DNA-Based and AI Powered Medical Consultations
VANCOUVER, BC, Feb. 9, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM3), is pleased to state that further to its news release dated January 14, 2021, announcing its letter of intent with Kayan Health Limited ("Kayan Health"), Kayan Health has signed a Memorandum of Understanding ("MoU") with Predictiv Care, Inc. ("Predictiv"), a personalized genomics technology platform aimed at empowering healthcare professionals with predictive medicine.
Jan 27, 2021 08:00 am ET
Beyond Medical Applauds President Biden's 100 Day Mask Wearing Mandate and Plans to Submit Tenders to US State Governments
VANCOUVER, BC, Jan. 27, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM3) applauds President Biden's actions in his first week as President. Thus far, President Biden has signed two executive orders mandating mask wearing in an effort to prevent the spread of Covid-19.
Jan 20, 2021 08:00 am ET
Kayan Health Launches Virtual Medical 'Second Opinion' Platform and Beyond Medical Amends Terms of Private Placement
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Jan 14, 2021 08:30 am ET
Beyond Medical to Acquire Telehealth Company Kayan Health
VANCOUVER, BC, Jan. 14, 2021 /CNW/ - Beyond Medical Technologies ("Beyond Medical" or the "Company") (CSE: DOCT) (Frankfurt: 7FM2), is pleased to announce that it has entered into a letter of intent (the "Letter of Intent") with Kayan Health Limited ("Kayan Health") which sets out the basic terms and conditions for the acquisition by the Company of all the issued and outstanding securities of Kayan Health in exchange for securities of the Company (the "Transaction"). Following completion of the Transaction, Kayan Health will become a wholly-owned subsidiary of the Company.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.